Form 4 holding
Director
GLYCOMIMETICS INC
- Security class
- Common Stock
- Shares / value
- 24,828
- Estimated value
- $74,484
- Report date
- 29 Mar 2024
- Price
- $3.00
- Ownership
- Direct
Mark Alan Goldberg - Director at CRESCENT BIOPHARMA, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CBIO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark Alan Goldberg since 22 Oct 2025
Reported holdings for Mark Alan Goldberg in CRESCENT BIOPHARMA, INC.
Form 4 holding
Director
GLYCOMIMETICS INC
- Security class
- Common Stock
- Shares / value
- 11,497
- Estimated value
- $34,491
- Report date
- 29 Mar 2024
- Price
- $3.00
- Ownership
- By family trusts
Form 4 holding
Director
GLYCOMIMETICS INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 01 May 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark Alan Goldberg in CRESCENT BIOPHARMA, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.